메뉴 건너뛰기




Volumn 22, Issue 10, 2015, Pages 1354-1362

Control of main risk factors after ischaemic stroke across Europe: Data from the stroke-specific module of the EUROASPIRE III survey

Author keywords

Cardiovascular disease; EUROASPIRE; Risk factors; Secondary prevention; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; CARDIOVASCULAR AGENT;

EID: 84944875791     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487314546825     Document Type: Review
Times cited : (89)

References (24)
  • 1
    • 61849116330 scopus 로고    scopus 로고
    • Cardiovascular prevention guidelines in daily practice: A comparison of EUROASPIRE I, II, and III surveys in eight European countries
    • Kotseva K, Wood D, De Backer G, et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009;373:929-940.
    • (2009) Lancet , vol.373 , pp. 929-940
    • Kotseva, K.1    Wood, D.2    De Backer, G.3
  • 2
    • 61849163580 scopus 로고    scopus 로고
    • EUROASPIRE III: A survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
    • Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009;16:121-137.
    • (2009) Eur J Cardiovasc Prev Rehabil , vol.16 , pp. 121-137
    • Kotseva, K.1    Wood, D.2    De Backer, G.3
  • 3
    • 4344575902 scopus 로고    scopus 로고
    • European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice
    • De Backer G, Ambrossioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2003;10:1-78.
    • (2003) Eur J Cardiovasc Prev Rehabil , vol.10 , pp. 1-78
    • De Backer, G.1    Ambrossioni, E.2    Borch-Johnsen, K.3
  • 4
    • 77955014011 scopus 로고    scopus 로고
    • Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study
    • O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112-123.
    • (2010) Lancet , vol.376 , pp. 112-123
    • O'Donnell, M.J.1    Xavier, D.2    Liu, L.3
  • 5
    • 0043013350 scopus 로고    scopus 로고
    • Stroke epidemiology: A review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century
    • Feigin VL, Lawes CMM, Bennett DA, et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003;2:43-53.
    • (2003) Lancet Neurol , vol.2 , pp. 43-53
    • Feigin, V.L.1    Lawes, C.M.M.2    Bennett, D.A.3
  • 6
    • 0038612838 scopus 로고    scopus 로고
    • Incidence, risk factors and prognosis of stroke and TIA: The need for high-quality, large-scale epidemiological studies and meta-analyses
    • Rothwell PM. Incidence, risk factors and prognosis of stroke and TIA: the need for high-quality, large-scale epidemiological studies and meta-analyses. Cerebrovasc Dis 2003;16:2-10.
    • (2003) Cerebrovasc Dis , vol.16 , pp. 2-10
    • Rothwell, P.M.1
  • 8
    • 10744221456 scopus 로고    scopus 로고
    • European stroke initiative recommendations for stroke management - Update 2003
    • The European Stroke Initiative Executive Committee and the EUSI Writing Committee. European Stroke Initiative Recommendations for Stroke Management - Update 2003. Cerebrovasc Dis 2003;16:311-337.
    • (2003) Cerebrovasc Dis , vol.16 , pp. 311-337
  • 9
    • 9144248446 scopus 로고    scopus 로고
    • Hypertension treatment and control in five European countries, Canada, and the United States
    • Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-17.
    • (2004) Hypertension , vol.43 , pp. 10-17
    • Wolf-Maier, K.1    Cooper, R.S.2    Kramer, H.3
  • 10
    • 0036284168 scopus 로고    scopus 로고
    • How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack?
    • Mouradian MS, Majumdar SR, Senthilselvan A, et al. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke 2002;33:1656-1659.
    • (2002) Stroke , vol.33 , pp. 1656-1659
    • Mouradian, M.S.1    Majumdar, S.R.2    Senthilselvan, A.3
  • 11
    • 0030801193 scopus 로고    scopus 로고
    • Modeling of risk factors for ischemic stroke. The Willis Lecture
    • Whisnant JP. Modeling of risk factors for ischemic stroke. The Willis Lecture. Stroke 1997;28:1840-1844.
    • (1997) Stroke , vol.28 , pp. 1840-1844
    • Whisnant, J.P.1
  • 12
    • 0034630424 scopus 로고    scopus 로고
    • Effect of smoking cessation on mortality after myocardial infarction
    • Wilson K, Gibson N, Willan A, et al. Effect of smoking cessation on mortality after myocardial infarction. Arch Intern Med 2000;160:939-944.
    • (2000) Arch Intern Med , vol.160 , pp. 939-944
    • Wilson, K.1    Gibson, N.2    Willan, A.3
  • 13
    • 0036714275 scopus 로고    scopus 로고
    • Cessation of smoking after first-ever stroke. A follow-up study
    • Bak S, Sindrup SH, Alslev T, et al. Cessation of smoking after first-ever stroke. A follow-up study. Stroke 2002;33:2263-2269.
    • (2002) Stroke , vol.33 , pp. 2263-2269
    • Bak, S.1    Sindrup, S.H.2    Alslev, T.3
  • 14
    • 84881100168 scopus 로고    scopus 로고
    • Statins in the primary prevention of cardiovascular disease
    • Reiner Z. Statins in the primary prevention of cardiovascular disease. Nat Rev Cardiol 2013;10:453-464.
    • (2013) Nat Rev Cardiol , vol.10 , pp. 453-464
    • Reiner, Z.1
  • 15
    • 84888120293 scopus 로고    scopus 로고
    • Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: Findings from the EUROASPIRE III survey
    • Reiner Z, De Bacquer D, Kotseva K, et al. Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey. Atherosclerosis 2013;231:300-307.
    • (2013) Atherosclerosis , vol.231 , pp. 300-307
    • Reiner, Z.1    De Bacquer, D.2    Kotseva, K.3
  • 16
    • 79960539641 scopus 로고    scopus 로고
    • ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
    • Reiner Z, Catapano AL, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32:1769-1818.
    • (2011) Eur Heart J , vol.32 , pp. 1769-1818
    • Reiner, Z.1    Catapano, A.L.2    De Backer, G.3
  • 17
    • 84862119222 scopus 로고    scopus 로고
    • European guidelines on cardiovascular disease prevention in clinical practice
    • Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2012;33:1635-1701.
    • (2012) Eur Heart J , vol.33 , pp. 1635-1701
    • Perk, J.1    De Backer, G.2    Gohlke, H.3
  • 18
    • 35148892823 scopus 로고    scopus 로고
    • European guidelines on cardiovascular disease prevention in clinical practice
    • Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2007;28:2375-2414.
    • (2007) Eur Heart J , vol.28 , pp. 2375-2414
    • Graham, I.1    Atar, D.2    Borch-Johnsen, K.3
  • 19
    • 18244371396 scopus 로고    scopus 로고
    • Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention
    • Perreault S, Blais L, Lamarre D, et al. Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. Br J Clin Pharmacol 2005;59:564-573.
    • (2005) Br J Clin Pharmacol , vol.59 , pp. 564-573
    • Perreault, S.1    Blais, L.2    Lamarre, D.3
  • 20
    • 84884930035 scopus 로고    scopus 로고
    • Prevalence and types of persistent dyslipidaemia in patients treated with statins
    • Reiner Z and Tedeschi-Reiner E. Prevalence and types of persistent dyslipidaemia in patients treated with statins. Croat Med J 2013;54:339-345.
    • (2013) Croat Med J , vol.54 , pp. 339-345
    • Reiner, Z.1    Tedeschi-Reiner, E.2
  • 22
    • 84899501931 scopus 로고    scopus 로고
    • Lifestyle interventions for secondary disease prevention in stroke and transient ischaemic attack: A systematic review
    • Lennon O, Galvin R, Smith K, et al. Lifestyle interventions for secondary disease prevention in stroke and transient ischaemic attack: a systematic review. Eur J Prev Cardiol 2013;20:1-14.
    • (2013) Eur J Prev Cardiol , vol.20 , pp. 1-14
    • Lennon, O.1    Galvin, R.2    Smith, K.3
  • 23
    • 78149336694 scopus 로고    scopus 로고
    • Cluster randomized controlled trial of a patient and general practitioner intervention to improve the management of multiple risk factors after stroke: Stop stroke
    • Wolfe CDA, Redfern J, Rudd AG, et al. Cluster randomized controlled trial of a patient and general practitioner intervention to improve the management of multiple risk factors after stroke: stop stroke. Stroke 2010;41:2470-2476.
    • (2010) Stroke , vol.41 , pp. 2470-2476
    • Wolfe, C.D.A.1    Redfern, J.2    Rudd, A.G.3
  • 24
    • 84872675138 scopus 로고    scopus 로고
    • Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPIRE-TMS): A protocol for a randomised controlled trial
    • Leistner S, Michelson G, Laumeier I, et al. Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPIRE-TMS): a protocol for a randomised controlled trial. BMC Neurol 2013;13:8-11.
    • (2013) BMC Neurol , vol.13 , pp. 8-11
    • Leistner, S.1    Michelson, G.2    Laumeier, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.